PuSH - Publikationsserver des Helmholtz Zentrums München

239 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Gallegos, P.A. et al.: Presence of markers associated with viral infections in the pancreas before and after onset of type 1 diabetes. Diabetologia 63, 1, S157-S157 (2020)
22.
Ghalwash, M.* et al.: Optimal ages for screening for type 1 diabetes risk in children. Diabetologia 63, 1, S181-S181 (2020)
23.
Hummel, J. et al.: Brain insulin sensitivity is modulated by menstrual cycle. Diabetologia 63, 1, S14-S14 (2020)
24.
Jall, S. et al.: Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity. Diabetologia 63, 1236-1247 (2020)
25.
Khamis, A.* et al.: Pnliprp1 hypermethylation in human exocrine pancreas reveals a link between diabetes and pancreatic cancer. Diabetologia 63, 1, S109-S109 (2020)
26.
Koivula, R.W.* et al.: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: An IMI DIRECT study. Diabetologia 63, 744-756 (2020)
27.
Koivula, R.W.* et al.: Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study (Diabetologia, (2020), 63, 4, (744-756), 10.1007/s00125-019-05083-6). Diabetologia 64, 260-261 (2020)
28.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes. Diabetologia 63, 1, S13-S14 (2020)
29.
Kwon, B.* et al.: A visual analytics method to explore the evolution of autoantibodies during progression to type 1 diabetes in multi-site birth cohort studies. Diabetologia 63, 1, S159-S159 (2020)
30.
Lamprinou, A.* et al.: Evaluation of determinants of hepatic insulin clearance: a Mendelian randomisation study. Diabetologia 63, 1, S36-S37 (2020)
31.
Marinicova, Z. et al.: Presentation of insulin granule derived peptides on MHC I in Enterovirus-infected beta cells and type 1 diabetes. Diabetologia 63, 1, S111-S111 (2020)
32.
Mattila, M.* et al.: Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: The TEDDY study. Diabetologia 63, 278-286 (2020)
33.
Oquendo, M.B. et al.: Comparison between in vitro differentiation of pancreatic and subcutaneous adipocytes of subjects with normal glucose tolerance. Diabetologia 63, 1, S254-S255 (2020)
34.
Scarale, M.* et al.: Circulating metabolites significantly improve the prediction of renal dysfunction in type 2 diabetes. Diabetologia 63, 1, S3-S3 (2020)
35.
Scarale, M.* et al.: Building clinical risk score systems for predicting all-cause and cardiovascular-specific mortality among type 2 diabetes patients. Diabetologia 63, S3-S4 (2020)
36.
Suleiman, M.* et al.: Glucose-lowering therapy and ex-vivo beta cell function in type 2 diabetes. Diabetologia 63, 1, S196-S196 (2020)
37.
van Krieken, P.P.* ; Odermatt, T.S.* ; Blüher, M. ; Wueest, S.* & Konrad, D.*: Oncostatin M inhibits browning of white adipose tissue via gp130 signalling. Diabetologia 63, 1, S21-S22 (2020)
38.
Vasiljević, J. ; Torkko, J.M. ; Knoch, K.-P. & Solimena, M.: The making of insulin in health and disease. Diabetologia 63, 1981-1989 (2020)
39.
Vasiljevic, J. et al.: Post-transcriptional co-regulation of insulin secretory granule proteins. Diabetologia 63, 1, S7-S8 (2020)
40.
Vosseler, A. et al.: Postprandial thermogenesis is reduced in obesity. Diabetologia 63, 1, S258-S258 (2020)